echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > A group of pharmaceutical companies were punished! Because of the suspected false lysing of special VAT invoices.

    A group of pharmaceutical companies were punished! Because of the suspected false lysing of special VAT invoices.

    • Last Update: 2020-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Pharmaceutical Network Industry Dynamics" With the two-vote system, the promotion of national volume procurement, not only regulate the circulation of drugs in the pharmaceutical industry, but also make pharmaceutical companies tax compliance requirements continue to improveOn July 15,, Guangdong Province announced a number of cases involving pharmaceutical enterprises suspected of falsely opening special VAT invoices, the number of up to 7 cases; In addition, since this year, Hainan, Henan, Hubei, Sichuan, Hunan, Qingdao and other provinces and cities have a number of pharmaceutical enterprises suspected of falsely opening special VAT invoices were punishedthese cases of false VAT invoices, involving taxes ranging from several thousand yuan to tens of millions of dollars, most of which ranged from millions of dollarsaccording to the industry, "two-vote system" after the implementation of the drug circulation link rebates, rebates and other costs can no longer be through multiple invoicing for the distribution of benefits, which also makes many pharmaceutical companies in the name of consulting fees, conference fees, marketing fees, such as a large number of large, large-scale false invoices into the account, so that sales costs "water rise ship high."in fact, in recent years, false invoicing, tax evasion and other tax-related violations have become the focus of the work of correcting the improper trend in the field of pharmaceutical purchase and sale and medical servicesin 2015, requires to verify the flow of bill funds and the flow of pharmaceutical logistics consistency for the grasp of "hanging on to leave ticket"; In 2018, in the pharmaceutical and pharmaceutical supplies purchase and sale link, focus on combating the non-implementation of the "two-vote system", false tax tickets, to wholesale business operators, focus on the fight against malicious cooperation with production enterprises "ticket laundering", in 2019, to combat the pharmaceutical industry false invoicing and other tax-related illegal acts;more than that, and taxes on the pharmaceutical industry continueOn June 5,, the State Medical Security Administration issued the Guidance on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment (Second Draft for Comments)the guidance, the establishment of a list of pharmaceutical prices and breach of trust matters, including but not limited to pharmaceutical commercial bribery, market price manipulation, violation of contract agreements, disruption of procurement order and other illegal and illegal acts, contrary to good faith and fair competitionFrom the date of the issuance of the guidance, pharmaceutical enterprises that engage in unfair competition and obtain improper benefits through the acts listed in the catalogue will be included in the scope of credit evaluation of pharmaceutical prices and tender procurementOn the same day, the National Health and Health Commission and other 9 ministries jointly issued the "Notice on the issuance of 2020 to correct the pharmaceutical purchase and sale of the field and medical services in the field of improper work points", which clearly put forward the discovery of the field of pharmaceutical production and circulation of false invoicing, tax evasion and other tax-related crimes in accordance with the lawcan see that the pharmaceutical industry will be more and more stringent tax, the production, sales and other links of enterprises will be more and more transparent, while the relevant enterprises will be more and more illegal costspharmaceutical companies can go further only if they are tax-compliant in the industry," the pharmaceutical industry is indeed facing a lot of survival pressure, in the current environment, how to increase profits while minimizing unnecessary costs, this is a huge challenge the financial and tax processing power of pharmaceutical enterprises determines the key to the success of enterprise transformation " tax cost is an important part of the enterprise cost, the enterprise's tax cost to effectively plan, the development of enterprises plays an important role "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.